Comparative Controlled Study of Analgesic, Antiasthenic and Anti-Anxiety Effects of Xenon in Patients With Parkinson's Disease
Condition: Parkinson Disease Interventions: Drug: NBTX-001; Drug: Standard of Care Sponsor: Nobilis Therapeutics Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials